What Passage Bio Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 0 | 2 |
| Total trades | 0 | 5 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 15,000 |
| Disposed | 0 | 6,138 |
| Net activity | +0 | +8,862 |
Common stock only — 1 reported trade in the last 12 months is in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management Lp | 10% owner | Jun 25 | Open-market buy · P | +50,055 | $4.12 | +$206K | 673,759 |
| Chou William | PRESIDENT AND CEO | Jan 08 | Open-market sale · S | −4,076 | $18.44 | −$75.2K | 6,524 |
| Chou William | PRESIDENT AND CEO | Jan 08 | Exercise / conversion · M | +10,000 | — | — | 10,600 |
| Borthwick Kathleen | CFO | Jan 08 | Open-market sale · S | −2,062 | $18.44 | −$38K | 5,402 |
| Borthwick Kathleen | CFO | Jan 08 | Exercise / conversion · M | +5,000 | — | — | 7,464 |
| Lynx1 Capital Management Lp | 10% owner | Sep 15 | Open-market buy · P | +11,900 | $6.99 | +$83.2K | 623,704 |
| Lynx1 Capital Management Lp | 10% owner | Sep 12 | Open-market buy · P | +19,783 | $6.99 | +$138K | 611,804 |
| Lynx1 Capital Management Lp | 10% owner | Sep 11 | Open-market buy · P | +325 | $6.96 | +$2.26K | 592,021 |
| Lynx1 Capital Management Lp | 10% owner | Jul 24 | Open-market buy · P | +66,423 | $5.71 | +$379K | 591,696 |
| Lynx1 Capital Management Lp | 10% owner | Jul 23 | Open-market buy · P | +49,302 | $5.74 | +$283K | 525,273 |
| Lynx1 Capital Management Lp | 10% owner | Jul 22 | Open-market buy · P | +13,123 | $5.44 | +$71.3K | 475,971 |
| Orbimed Advisors Llc | 10% owner | Jun 26 | Open-market sale · S | −213,257 | $0.33 | −$70.4K | 6,066,343 |
| Orbimed Advisors Llc | 10% owner | Jun 25 | Open-market sale · S | −138,800 | $0.33 | −$45.8K | 6,279,600 |
| Orbimed Advisors Llc | 10% owner | Jun 24 | Open-market sale · S | −231,600 | $0.35 | −$81.1K | 6,418,400 |
| Orbimed Advisors Llc | 10% owner | Apr 24 | Open-market sale · S | −68,195 | $0.32 | −$21.8K | 6,650,000 |
| Orbimed Advisors Llc | 10% owner | Apr 23 | Open-market sale · S | −89,328 | $0.34 | −$30.4K | 6,718,195 |
| Orbimed Advisors Llc | 10% owner | Apr 22 | Open-market sale · S | −78,049 | $0.34 | −$26.5K | 6,807,523 |
| Orbimed Advisors Llc | 10% owner | Apr 17 | Open-market sale · S | −77,090 | $0.33 | −$25.4K | 6,885,572 |
| Orbimed Advisors Llc | 10% owner | Apr 16 | Open-market sale · S | −61,638 | $0.33 | −$20.3K | 6,962,662 |
| Orbimed Advisors Llc | 10% owner | Apr 15 | Open-market sale · S | −10,326 | $0.38 | −$3.92K | 7,024,300 |
Loading...